Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis

OBJECTIVE: Most guidelines recommend the use of nonsteroidal anti-inflammatory drugs (NSAIDs), duloxetine, and tramadol for the nonoperative treatment of osteoarthritis (OA), but the use of them is limited by the tolerability and safety concerns. Lutikizumab is a novel anti–IL-1α/β dual variable dom...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ziqin, Li, Yajia, Wang, Wanchun, Jie, Shuo, Hu, Xuantao, Zhou, Jian, Wu, Tong, Aili, Dilihumaer, Long, Zeling, Li, Yihan, Dou, Pengcheng, Wu, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661137/
https://www.ncbi.nlm.nih.gov/pubmed/33204726
http://dx.doi.org/10.1155/2020/9013283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661137/
https://www.ncbi.nlm.nih.gov/pubmed/33204726
http://dx.doi.org/10.1155/2020/9013283

Ejemplares similares